BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

neoX Biotech

neoX Biotech logo

Website
https://www.neoxbiotech.com/
Founded
2018
Publications
6

Technologies

AI Companies (Drug Discovery) Antibody Discovery Companies

neoX Biotech is a biotech company that combines artificial intelligence (AI) with biophysics for drug research and development. neoX focuses on the research and development of macromolecular drugs and multi-specific drugs, especially in the field of immuno-oncology. It has developed a sophisticated platform for early discovery of therapeutics by characterizing protein-protein interactions (PPI). neoX has established cooperation with biomedical companies globally to accelerate drug R&D pipelines. Founded in 2018 by two doctors graduated from MIT and Caltech, neoX has been funded by top venture capitals including Sequoia Capital, Morningside Venture Capital, Vision Plus Capital and ZhenFund.

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

Star Kang original biological (neoX Biotech) to complete millions of dollars in early 7 pre-A round of financing, this round of financing is mainly used to extend the expansion, high-throughput laboratory personnel team and advance drug development pipeline cooperation. Prior to this, Xingkang Original Bio had received millions of dollars in angel investment from Morningside Capital and Zhen Fund. Xingkang original biology currently focuses on the development of new antigens, PROTAC and antibody drugs. The neoX high-throughput neoantigen-TCR computational screening platform can establish a neoantigen library and a TCR library from the gene sequencing and high-throughput single cell sequencing data of tumor cells of a single cancer patient, and find the best solution. The neoX computing platform optimizes the "target protein-PROTAC-E3 ligase" ternary complex by designing the protein-protein interface and virtual screening of the PROTAC compound library, and designing and obtaining lead compounds more efficiently.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.